Relationship between HER-2 amplification and tumor infiltrating lymphocytes in breast cancer patients treated with neoadjuvant trastuzumab
Gespeichert in:
Veröffentlicht in: | Annals of oncology 2016-09, Vol.27, p.iv64 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | iv64 |
container_title | Annals of oncology |
container_volume | 27 |
creator | Masini, C. Bisagni, G. Ragazzi, M. Bisagni, A. Dallaglio, K. Falco, G. Ferrari, G. Bassano, C. Gardini, G. Bologna, A. Moretti, G. Boni, C. Baldi, L. Pinto, C. |
description | |
doi_str_mv | 10.1093/annonc/mdw337.18 |
format | Article |
fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdw337_18</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_annonc_mdw337_18</sourcerecordid><originalsourceid>FETCH-LOGICAL-c838-f46f1bee7cfb874c728e4719233285dac00cbedeb280c2fc72cf0b494a89f0ec3</originalsourceid><addsrcrecordid>eNotkNFKwzAUhnOh4Jzee5kX6JYm3ZpeyphOGAhj9yU5PXEZbVqS1DEfwac2Wq8O_N_PD-cj5Clni5xVYqmc6x0su-YiRLnI5Q2ZsYqLrFyJ4o7ch3BmjK0rXs3I9wFbFW3vwskOVGO8IDq62x4yTlU3tNZY-ONUuYbGses9tc7YNvoUuw_aXrvh1MM1YkiAao8qRArKAXo6pA66GGhMccSGXmw8UYe9as7jp3IxgVQfv8ZO6Qdya1Qb8PH_zsnxZXvc7LL9--vb5nmfgRQyM8Xa5BqxBKNlWUDJJRZlnt4TXK4aBYyBxgY1lwy4SRwM00VVKFkZhiDmhE2z4PsQPJp68LZT_lrnrP7VV0_66klfnUvxA7lLbZ8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Relationship between HER-2 amplification and tumor infiltrating lymphocytes in breast cancer patients treated with neoadjuvant trastuzumab</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Masini, C. ; Bisagni, G. ; Ragazzi, M. ; Bisagni, A. ; Dallaglio, K. ; Falco, G. ; Ferrari, G. ; Bassano, C. ; Gardini, G. ; Bologna, A. ; Moretti, G. ; Boni, C. ; Baldi, L. ; Pinto, C.</creator><creatorcontrib>Masini, C. ; Bisagni, G. ; Ragazzi, M. ; Bisagni, A. ; Dallaglio, K. ; Falco, G. ; Ferrari, G. ; Bassano, C. ; Gardini, G. ; Bologna, A. ; Moretti, G. ; Boni, C. ; Baldi, L. ; Pinto, C.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>DOI: 10.1093/annonc/mdw337.18</identifier><language>eng</language><ispartof>Annals of oncology, 2016-09, Vol.27, p.iv64</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids></links><search><creatorcontrib>Masini, C.</creatorcontrib><creatorcontrib>Bisagni, G.</creatorcontrib><creatorcontrib>Ragazzi, M.</creatorcontrib><creatorcontrib>Bisagni, A.</creatorcontrib><creatorcontrib>Dallaglio, K.</creatorcontrib><creatorcontrib>Falco, G.</creatorcontrib><creatorcontrib>Ferrari, G.</creatorcontrib><creatorcontrib>Bassano, C.</creatorcontrib><creatorcontrib>Gardini, G.</creatorcontrib><creatorcontrib>Bologna, A.</creatorcontrib><creatorcontrib>Moretti, G.</creatorcontrib><creatorcontrib>Boni, C.</creatorcontrib><creatorcontrib>Baldi, L.</creatorcontrib><creatorcontrib>Pinto, C.</creatorcontrib><title>Relationship between HER-2 amplification and tumor infiltrating lymphocytes in breast cancer patients treated with neoadjuvant trastuzumab</title><title>Annals of oncology</title><issn>0923-7534</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNotkNFKwzAUhnOh4Jzee5kX6JYm3ZpeyphOGAhj9yU5PXEZbVqS1DEfwac2Wq8O_N_PD-cj5Clni5xVYqmc6x0su-YiRLnI5Q2ZsYqLrFyJ4o7ch3BmjK0rXs3I9wFbFW3vwskOVGO8IDq62x4yTlU3tNZY-ONUuYbGses9tc7YNvoUuw_aXrvh1MM1YkiAao8qRArKAXo6pA66GGhMccSGXmw8UYe9as7jp3IxgVQfv8ZO6Qdya1Qb8PH_zsnxZXvc7LL9--vb5nmfgRQyM8Xa5BqxBKNlWUDJJRZlnt4TXK4aBYyBxgY1lwy4SRwM00VVKFkZhiDmhE2z4PsQPJp68LZT_lrnrP7VV0_66klfnUvxA7lLbZ8</recordid><startdate>201609</startdate><enddate>201609</enddate><creator>Masini, C.</creator><creator>Bisagni, G.</creator><creator>Ragazzi, M.</creator><creator>Bisagni, A.</creator><creator>Dallaglio, K.</creator><creator>Falco, G.</creator><creator>Ferrari, G.</creator><creator>Bassano, C.</creator><creator>Gardini, G.</creator><creator>Bologna, A.</creator><creator>Moretti, G.</creator><creator>Boni, C.</creator><creator>Baldi, L.</creator><creator>Pinto, C.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201609</creationdate><title>Relationship between HER-2 amplification and tumor infiltrating lymphocytes in breast cancer patients treated with neoadjuvant trastuzumab</title><author>Masini, C. ; Bisagni, G. ; Ragazzi, M. ; Bisagni, A. ; Dallaglio, K. ; Falco, G. ; Ferrari, G. ; Bassano, C. ; Gardini, G. ; Bologna, A. ; Moretti, G. ; Boni, C. ; Baldi, L. ; Pinto, C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c838-f46f1bee7cfb874c728e4719233285dac00cbedeb280c2fc72cf0b494a89f0ec3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Masini, C.</creatorcontrib><creatorcontrib>Bisagni, G.</creatorcontrib><creatorcontrib>Ragazzi, M.</creatorcontrib><creatorcontrib>Bisagni, A.</creatorcontrib><creatorcontrib>Dallaglio, K.</creatorcontrib><creatorcontrib>Falco, G.</creatorcontrib><creatorcontrib>Ferrari, G.</creatorcontrib><creatorcontrib>Bassano, C.</creatorcontrib><creatorcontrib>Gardini, G.</creatorcontrib><creatorcontrib>Bologna, A.</creatorcontrib><creatorcontrib>Moretti, G.</creatorcontrib><creatorcontrib>Boni, C.</creatorcontrib><creatorcontrib>Baldi, L.</creatorcontrib><creatorcontrib>Pinto, C.</creatorcontrib><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Masini, C.</au><au>Bisagni, G.</au><au>Ragazzi, M.</au><au>Bisagni, A.</au><au>Dallaglio, K.</au><au>Falco, G.</au><au>Ferrari, G.</au><au>Bassano, C.</au><au>Gardini, G.</au><au>Bologna, A.</au><au>Moretti, G.</au><au>Boni, C.</au><au>Baldi, L.</au><au>Pinto, C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Relationship between HER-2 amplification and tumor infiltrating lymphocytes in breast cancer patients treated with neoadjuvant trastuzumab</atitle><jtitle>Annals of oncology</jtitle><date>2016-09</date><risdate>2016</risdate><volume>27</volume><spage>iv64</spage><pages>iv64-</pages><issn>0923-7534</issn><doi>10.1093/annonc/mdw337.18</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0923-7534 |
ispartof | Annals of oncology, 2016-09, Vol.27, p.iv64 |
issn | 0923-7534 |
language | eng |
recordid | cdi_crossref_primary_10_1093_annonc_mdw337_18 |
source | EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
title | Relationship between HER-2 amplification and tumor infiltrating lymphocytes in breast cancer patients treated with neoadjuvant trastuzumab |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T15%3A38%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Relationship%20between%20HER-2%20amplification%20and%20tumor%20infiltrating%20lymphocytes%20in%20breast%20cancer%20patients%20treated%20with%20neoadjuvant%20trastuzumab&rft.jtitle=Annals%20of%20oncology&rft.au=Masini,%20C.&rft.date=2016-09&rft.volume=27&rft.spage=iv64&rft.pages=iv64-&rft.issn=0923-7534&rft_id=info:doi/10.1093/annonc/mdw337.18&rft_dat=%3Ccrossref%3E10_1093_annonc_mdw337_18%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |